Diagnosed With Cancer After Taking Zantac or Another Ranitidine Product?

You May Be Entitled To Compensation

  • Zantac Lawsuit Justice Center

Steering Committee For Zantac Lawsuit Names Roopal Luhana

Updated: Jun 17



The Zantac MDL was established by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on Feb. 6, 2020. All federally filed Zantac lawsuits are now consolidated (and future federal cases will be transferred) to Judge Rosenberg in the Southern District of Florida, where pretrial proceedings will take place.


“I’m honored that Judge Rosenberg appointed and entrusted me to assist in steering this litigation. I believe the position allows me and my firm to actively advocate for our clients and plaintiffs generally.” said Luhana, one of 13 women chosen for leadership.

“You should be able to trust that when taking a medication – prescribed or over the counter like Zantac (ranitidine) – that you would be safe from potential exposure to carcinogens resulting in cancer, which is what is alleged in this case. I’m excited and ready to move this litigation forward with my colleagues, so we can resolve these issues efficiently and fairly for all plaintiffs.”


Most recently, on April 1, the U.S. Food and Drug Administration (the “FDA”) requested that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.


This was the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The FDA has determined that the impurity in some ranitidine products increases over time even under normal storage conditions, and when stored at higher than room temperatures, the NDMA levels increase significantly and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S.


People who used Zantac for years to treat various conditions such as ulcers, gastroesophageal reflux disease (GERD), common heartburn, and more, are now understandably concerned about their potential exposure to NDMA, and what that means for their health.


Some have already been diagnosed with cancers linked to NDMA.

Plaintiffs filing lawsuits against Zantac manufacturers argue that the defendants were aware of the risks associated with ranitidine for decades, yet concealed these risks from healthcare providers and the general public.






Zantac Lawsuit | Settlement & Class Action
  • White LinkedIn Icon
  • Facebook | Zantac Lawsuit

© 2020 ZantacLawsuit.com. All Rights Reserved. (Privacy Policy)

The information provided by ZantacLawsuit.com is not a substitute for professional medical advice, diagnosis or treatment. The views and opinions expressed on the site do not necessarily represent those of ZantacLawsuit.com. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your client's copyright, we may be contacted concerning copyright matters at: webmaster@zantaclawsuit.com